Retractable Technologies Inc (RVP)
0.5988
+0.01
(+2.13%)
USD |
NYAM |
Nov 21, 16:00
0.5988
0.00 (0.00%)
After-Hours: 20:00
Retractable Technologies Enterprise Value: -17.60M for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | -17.60M |
| November 19, 2024 | -17.64M |
| November 18, 2024 | -18.06M |
| November 15, 2024 | -16.75M |
| November 14, 2024 | -16.44M |
| November 13, 2024 | -14.47M |
| November 12, 2024 | -13.61M |
| November 11, 2024 | -13.85M |
| November 08, 2024 | -13.20M |
| November 07, 2024 | -13.30M |
| November 06, 2024 | -13.16M |
| November 05, 2024 | -13.45M |
| November 04, 2024 | -13.50M |
| November 01, 2024 | -13.90M |
| October 31, 2024 | -13.55M |
| October 30, 2024 | -13.78M |
| October 29, 2024 | -13.14M |
| October 28, 2024 | -13.00M |
| October 25, 2024 | -13.20M |
| October 24, 2024 | -13.30M |
| October 23, 2024 | -13.00M |
| October 22, 2024 | -12.41M |
| October 21, 2024 | -12.33M |
| October 18, 2024 | -12.40M |
| October 17, 2024 | -12.34M |
| Date | Value |
|---|---|
| October 16, 2024 | -11.53M |
| October 15, 2024 | -11.84M |
| October 14, 2024 | -12.44M |
| October 11, 2024 | -12.44M |
| October 10, 2024 | -12.55M |
| October 09, 2024 | -12.03M |
| October 08, 2024 | -12.05M |
| October 07, 2024 | -12.26M |
| October 04, 2024 | -12.67M |
| October 03, 2024 | -12.85M |
| October 02, 2024 | -12.11M |
| October 01, 2024 | -12.24M |
| September 30, 2024 | -12.10M |
| September 27, 2024 | -17.59M |
| September 26, 2024 | -18.70M |
| September 25, 2024 | -18.58M |
| September 24, 2024 | -17.83M |
| September 23, 2024 | -18.73M |
| September 20, 2024 | -16.96M |
| September 19, 2024 | -13.38M |
| September 18, 2024 | -13.63M |
| September 17, 2024 | -13.42M |
| September 16, 2024 | -13.34M |
| September 13, 2024 | -13.04M |
| September 12, 2024 | -13.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-18.73M
Minimum
Sep 23 2024
708.44M
Maximum
Feb 01 2021
121.23M
Average
42.64M
Median
Jan 16 2020
Enterprise Value Benchmarks
| Plus Therapeutics Inc | 5.521M |
| Perspective Therapeutics Inc | 150.86M |
| InfuSystems Holdings Inc | 219.39M |
| Xtant Medical Holdings Inc | 85.45M |
| Catheter Precision Inc | 3.843M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.922M |
| Revenue (Quarterly) | 10.35M |
| Total Expenses (Quarterly) | 15.48M |
| EPS Diluted (Quarterly) | -0.07 |
| Gross Profit Margin (Quarterly) | -0.14% |
| Profit Margin (Quarterly) | -18.58% |
| Earnings Yield | -90.18% |
| Normalized Earnings Yield | -90.10 |